Arcutis Biotherapeutics Inc (ARQT)
9.20
+0.08
(+0.88%)
USD |
NASDAQ |
May 17, 16:00
9.12
-0.08
(-0.87%)
After-Hours: 20:00
Arcutis Biotherapeutics Enterprise Value: 863.97M for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 863.97M |
| May 16, 2024 | 854.71M |
| May 15, 2024 | 868.60M |
| May 14, 2024 | 740.10M |
| May 13, 2024 | 723.89M |
| May 10, 2024 | 706.53M |
| May 09, 2024 | 725.45M |
| May 08, 2024 | 721.98M |
| May 07, 2024 | 709.27M |
| May 06, 2024 | 717.36M |
| May 03, 2024 | 723.14M |
| May 02, 2024 | 792.45M |
| May 01, 2024 | 820.18M |
| April 30, 2024 | 760.10M |
| April 29, 2024 | 813.25M |
| April 26, 2024 | 777.43M |
| April 25, 2024 | 791.30M |
| April 24, 2024 | 809.78M |
| April 23, 2024 | 808.63M |
| April 22, 2024 | 831.73M |
| April 19, 2024 | 850.04M |
| April 18, 2024 | 890.46M |
| April 17, 2024 | 982.87M |
| April 16, 2024 | 965.54M |
| April 15, 2024 | 964.39M |
| Date | Value |
|---|---|
| April 12, 2024 | 977.09M |
| April 11, 2024 | 1.171B |
| April 10, 2024 | 1.224B |
| April 09, 2024 | 1.242B |
| April 08, 2024 | 1.246B |
| April 05, 2024 | 1.109B |
| April 04, 2024 | 1.041B |
| April 03, 2024 | 911.25M |
| April 02, 2024 | 884.69M |
| April 01, 2024 | 917.03M |
| March 31, 2024 | 943.60M |
| March 28, 2024 | 1.069B |
| March 27, 2024 | 1.033B |
| March 26, 2024 | 995.72M |
| March 25, 2024 | 994.57M |
| March 22, 2024 | 1.035B |
| March 21, 2024 | 1.100B |
| March 20, 2024 | 1.172B |
| March 19, 2024 | 1.064B |
| March 18, 2024 | 1.107B |
| March 15, 2024 | 1.156B |
| March 14, 2024 | 1.188B |
| March 13, 2024 | 1.202B |
| March 12, 2024 | 1.092B |
| March 11, 2024 | 1.084B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
123.06M
Minimum
Oct 23 2023
1.552B
Maximum
Feb 08 2021
749.33M
Average
768.06M
Median
Enterprise Value Benchmarks
| AdaptHealth Corp | 3.458B |
| Prestige Consumer Healthcare Inc | 4.306B |
| Pfizer Inc | 219.35B |
| Adverum Biotechnologies Inc | -26.44M |
| Karuna Therapeutics Inc (DELISTED) | 11.34B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -35.38M |
| Revenue (Quarterly) | 49.57M |
| Total Expenses (Quarterly) | 81.19M |
| EPS Diluted (Quarterly) | -0.32 |
| Gross Profit Margin (Quarterly) | 93.43% |
| Profit Margin (Quarterly) | -71.38% |
| Earnings Yield | -31.85% |
| Normalized Earnings Yield | -31.85 |